1. Home
  2. BDTX vs SNCR Comparison

BDTX vs SNCR Comparison

Compare BDTX & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • SNCR
  • Stock Information
  • Founded
  • BDTX 2014
  • SNCR 2000
  • Country
  • BDTX United States
  • SNCR United States
  • Employees
  • BDTX N/A
  • SNCR N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • SNCR EDP Services
  • Sector
  • BDTX Health Care
  • SNCR Technology
  • Exchange
  • BDTX Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • BDTX 96.9M
  • SNCR 101.2M
  • IPO Year
  • BDTX 2020
  • SNCR 2006
  • Fundamental
  • Price
  • BDTX $1.61
  • SNCR $11.64
  • Analyst Decision
  • BDTX Strong Buy
  • SNCR Strong Buy
  • Analyst Count
  • BDTX 5
  • SNCR 1
  • Target Price
  • BDTX $15.60
  • SNCR $13.00
  • AVG Volume (30 Days)
  • BDTX 8.2M
  • SNCR 132.3K
  • Earning Date
  • BDTX 03-06-2025
  • SNCR 03-11-2025
  • Dividend Yield
  • BDTX N/A
  • SNCR N/A
  • EPS Growth
  • BDTX N/A
  • SNCR N/A
  • EPS
  • BDTX N/A
  • SNCR 0.43
  • Revenue
  • BDTX N/A
  • SNCR $173,594,000.00
  • Revenue This Year
  • BDTX N/A
  • SNCR $6.40
  • Revenue Next Year
  • BDTX N/A
  • SNCR N/A
  • P/E Ratio
  • BDTX N/A
  • SNCR $26.52
  • Revenue Growth
  • BDTX N/A
  • SNCR 5.72
  • 52 Week Low
  • BDTX $1.55
  • SNCR $6.02
  • 52 Week High
  • BDTX $7.66
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 38.60
  • SNCR 58.94
  • Support Level
  • BDTX $1.55
  • SNCR $11.65
  • Resistance Level
  • BDTX $1.84
  • SNCR $12.19
  • Average True Range (ATR)
  • BDTX 0.23
  • SNCR 0.93
  • MACD
  • BDTX 0.01
  • SNCR 0.11
  • Stochastic Oscillator
  • BDTX 5.26
  • SNCR 78.85

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: